Thalidomide therapy induces response in relapsed mantle cell lymphoma. - Wikidata - wikimedia - TriplyDB

Thalidomide therapy induces response in relapsed mantle cell lymphoma.

Thalidomide therapy induces response in relapsed mantle cell lymphoma.

http://www.wikidata.org/entity/Q44582819

about

Thalidomide plus chemotherapy exhibit enhanced efficacy in the clinical treatment of T-cell non-Hodgkin's lymphoma: A prospective study of 46 cases.Treatment of mantle cell lymphoma: targeting the microenvironment.Novel therapeutic targets in mantle cell lymphoma.A mental retardation-linked nonsense mutation in cereblon is rescued by proteasome inhibition.Lenalidomide inhibits lymphangiogenesis in preclinical models of mantle cell lymphoma Hematopoietic SCT for mantle cell lymphoma: is it the standard of care?Emerging agents for the treatment of mantle cell lymphoma.Therapeutic effects of thalidomide in hematologic disorders: a review.Management of mantle cell lymphoma in the elderly: current and potential strategies.Lenalidomide in relapsed or refractory mantle cell lymphoma: overview and perspective.Cereblon in health and disease.Single-agent thalidomide induces response in T-cell lymphoma.Thalidomide has limited single-agent activity in relapsed or refractory indolent non-Hodgkin lymphomas: a phase II trial of the Cancer and Leukemia Group B.

P2860

Q33932989-890DD989-2B88-435B-BBB2-F5B433C2AF13 Q36185624-3DD2C0E2-1C82-4B60-A689-8F89E0E72464 Q36871990-FF0D3168-4DBF-47FF-8738-20B3F72E18D3 Q37226149-A98C104F-DD3B-4EFB-9352-193A9488B73D Q37626685-7AB11822-012E-4F14-967E-F6CF93D91910 Q37728866-A2BCD178-916A-49FC-ADB5-5F3C4EBEA1EA Q38055498-84C8F6E2-B7B3-4C8A-9B55-3162A6B981AF Q38121762-2104A4B3-90DB-45BF-BB22-EEEB08E8C253 Q38157682-3C0DB776-B937-45D0-862E-3EA83FB8F482 Q38216650-44DB2C83-7AC2-4BC9-B985-CFE7B38A09DF Q38876495-0F14490D-983D-4520-85F4-31F1A6A28C21 Q45227579-8BE84751-9714-4D35-9EA7-03B2095DD6DC Q46793012-F45B6F0A-8F3F-48B4-B8CE-AF9EAE5DFDCD

P2860

Thalidomide therapy induces response in relapsed mantle cell lymphoma.

http://www.wikidata.org/entity/Q44582819

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh-hant

name

Thalidomide therapy induces response in relapsed mantle cell lymphoma.

@en

Thalidomide therapy induces response in relapsed mantle cell lymphoma.

@nl

type

label

Thalidomide therapy induces response in relapsed mantle cell lymphoma.

@en

Thalidomide therapy induces response in relapsed mantle cell lymphoma.

@nl

prefLabel

Thalidomide therapy induces response in relapsed mantle cell lymphoma.

@en

Thalidomide therapy induces response in relapsed mantle cell lymphoma.

@nl

P1433

Q44582819-659EE928-D4C1-40F2-9D38-60283BFF5921

P1476

Q44582819-2BDF3DB3-0942-44F2-B8B6-4CE8E1956E9B

P2093

Q44582819-01F9C750-DAFB-4F46-8D66-031DFC9F4002

Q44582819-7E97FC99-E30E-4F32-991A-EA167E74C6CA

Q44582819-8D81652A-1B6C-4BA3-9162-0ABFAB653228

Q44582819-B01EBF98-6804-4F8D-B0B9-2F05DCB8422A

Q44582819-FC78EF91-CE5D-4268-A0EB-04660FC3426D

P2860

Q44582819-0F320B9F-35AB-4DC8-AD80-96A0C8105D04

Q44582819-24302277-B957-45AF-8B68-034F93898A40

Q44582819-6F54CD97-83C2-415C-8DC2-B3FE396AC24D

Q44582819-743AA381-B4A0-43A8-805C-598942920EB5

Q44582819-8BA89B0A-D0F0-4576-A9E6-23020D8FD869

Q44582819-B279DA4F-4B30-4C62-8672-F8CC9B7D231E

Q44582819-CE752010-7305-49C1-AAB2-5A2D47F2457F

Q44582819-DA5D99A2-6947-489E-B1E6-9D3BFB345685

P2888

Q44582819-B2CF8C67-8ACF-4E8C-8CB6-01CF4564241C

P304

Q44582819-8BA00F82-3CE9-46EC-9ECB-6A79EAB511D1

P31

Q44582819-6CF688A4-6E72-4A21-A6F2-ED60445389EC

P356

Q44582819-28A3F370-2FA0-49A2-A027-735FD673891E

P433

Q44582819-30BA5EA4-0AE5-4AF5-AEFB-93BEB822F248

P478

Q44582819-BC819A38-2B54-421B-A4A8-DED3D1CA1B13

P50

Q44582819-22159A39-B9FF-4331-AFD6-9527F95C34AE

P577

Q44582819-4EBAD5D4-A2BF-4902-A883-1698F1A7FC54

P5875

Q44582819-C5CF3761-3905-4D39-9135-5464C5715435

P6179

Q44582819-0453B608-CAF6-4FD9-B1CA-42E49D182A26

P698

Q44582819-507E7497-ABC6-4ECD-840D-91DD7C498196

P921

Q44582819-2D0F4DF7-6B5C-46A4-AC3C-B27F3A9CFB31

P356

P1433

P1476

Thalidomide therapy induces response in relapsed mantle cell lymphoma.

@en

P2093

Damaj G

http://www.w3.org/2001/XMLSchema#string

Delarue R

http://www.w3.org/2001/XMLSchema#string

Furman R

http://www.w3.org/2001/XMLSchema#string

Lefrère F

http://www.w3.org/2001/XMLSchema#string

Varet B

http://www.w3.org/2001/XMLSchema#string

P2860

Thalidomide is an inhibitor of angiogenesis

Thalidomide for previously untreated indolent or smoldering multiple myeloma.

Antitumor activity of thalidomide in refractory multiple myeloma.

Thalidomide costimulates primary human T lymphocytes, preferentially inducing proliferation, cytokine production, and cytotoxic responses in the CD8+ subset.

Inhibition of NF-kappa B activity by thalidomide through suppression of IkappaB kinase activity.

Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma.

Sequential chemotherapy by CHOP and DHAP regimens followed by high-dose therapy with stem cell transplantation induces a high rate of complete response and improves event-free survival in mantle cell lymphoma: a prospective study.

Thalidomide as initial therapy for early-stage myeloma.

P2888

P304

1914-1915

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.LEU.2403058

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P50

Olivier Hermine

P577

2003-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10570192

http://www.w3.org/2001/XMLSchema#string

P6179

1028508855

http://www.w3.org/2001/XMLSchema#string

P698

12970798

http://www.w3.org/2001/XMLSchema#string

P921